{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.526.2.1761","meta":{"versionId":"5","lastUpdated":"2020-06-29T21:59:40.000-04:00"},"text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\">\n      <h2>Influenza Vaccination</h2>\n      <p>This value set includes codes from the following code systems:</p>\n      <ul>\n        <li>Include these codes as defined in \n          <code>http://www.nlm.nih.gov/research/umls/hcpcs</code>\n          <table class=\"none\">\n            <tr>\n              <td>\n                <b>Code</b>\n              </td>\n              <td>\n                <b>Display</b>\n              </td>\n            </tr>\n            <tr>\n              <td>G0008</td>\n              <td>Administration of influenza virus vaccine</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>Q2034</td>\n              <td>Influenza virus vaccine, split virus, for intramuscular use (agriflu)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>Q2035</td>\n              <td>Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>Q2036</td>\n              <td>Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>Q2037</td>\n              <td>Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>Q2038</td>\n              <td>Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>Q2039</td>\n              <td>Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (not otherwise specified)</td>\n              <td/>\n            </tr>\n          </table>\n        </li>\n      </ul>\n    </div>"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1761","version":"20170504","name":"Influenza Vaccination","status":"active","date":"2017-05-04T01:00:13-04:00","publisher":"NCQA PHEMUR","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","concept":[{"code":"G0008","display":"Administration of influenza virus vaccine"},{"code":"Q2034","display":"Influenza virus vaccine, split virus, for intramuscular use (agriflu)"},{"code":"Q2035","display":"Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria)"},{"code":"Q2036","display":"Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)"},{"code":"Q2037","display":"Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)"},{"code":"Q2038","display":"Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)"},{"code":"Q2039","display":"Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (not otherwise specified)"}]}]}}